Drug & intervention

esketamine

RxCUI 2119365

Clinical trials21
Recruiting5
Related conditions20
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

21 shown
A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive DisorderNCT07227454 · 2026-01-08
RECRUITING
Metabolic Profiling of Esketamine Treatment in Depressive DisorderNCT07002684 · 2023-04-01
RECRUITING
Long-Term Maintenance With Ketamine and Esketamine for Reduction of Suicide in High-Risk Patients With DepressionNCT05450432 · 2022-10-13
RECRUITING
University of Iowa Interventional Psychiatry Service Patient RegistryNCT04480918 · 2020-11-02
RECRUITING
Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity SurgeryNCT03756961 · 2019-05-01
RECRUITING
Esketamine in Microelectrode Recording-guided Subthalamic Deep-Brain Stimulation for Parkinson's DiseaseNCT06543563 · 2024-08-09
UNKNOWN
Behavioural Activation Therapy and Esketamine for Resistant DepressionNCT06431386 · 2024-06-11
TERMINATED
VA Aripiprazole vs Esketamine for Treatment Resistant DepressionNCT05554627 · 2023-10-27
WITHDRAWN
Dexmedetomidine-esketamine Combined Nasal Administration and Perioperative Sleep QualityNCT05732064 · 2023-05-22
COMPLETED
Ayahuasca and Esketamine for Major DepressionNCT07212946 · 2022-10-30
COMPLETED
Effect of Esketamine on Postoperative Depression、Gut Microbiota、Bispectral Index Data of Depression Patients Undergoing Breast Cancer Operation (ESPOD-BI)NCT04303325 · 2021-10-08
UNKNOWN
A Long-Term Extension Study for Participants With Treatment-resistant Major Depressive Disorder Who Are Continuing Esketamine Nasal Spray TreatmentNCT04829318 · 2021-04-26
COMPLETED
Esketamine and Perioperative Depressive SymptomsNCT04425473 · 2021-02-19
COMPLETED
Effect of Low-dose Esketamine on Postoperative Depression in Patients With Breast CancerNCT04850937 · 2021-02-10
COMPLETED
Imaging Neural Correlates of Ketamine Using PET/MRNCT04587778 · 2020-10-05
UNKNOWN
Study to Evaluate the Efficacy and Safety of 3 Fixed Doses of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Pediatric Participants Assessed to be at Imminent Risk for SuicideNCT03185819 · 2017-10-05
COMPLETED
54135419SUI3002: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for SuicideNCT03097133 · 2017-06-15
COMPLETED
54135419SUI3001: A Study to Evaluate the Efficacy and Safety of Intranasal Esketamine in Addition to Comprehensive Standard of Care for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Adult Participants Assessed to be at Imminent Risk for SuicideNCT03039192 · 2017-06-09
COMPLETED
A Study to Evaluate the Effects of a Single-Dose and Repeat-Administration of Intranasal Esketamine on On-Road Driving in Participants With Major Depressive DisorderNCT02919579 · 2016-10-07
COMPLETED
A Double-blind Study to Assess the Efficacy and Safety of Intranasal Esketamine for the Rapid Reduction of the Symptoms of Major Depressive Disorder, Including Suicidal Ideation, in Participants Who Are Assessed to be at Imminent Risk for SuicideNCT02133001 · 2014-05-23
COMPLETED
A Study of the Efficacy of Intravenous Esketamine in Adult Patients With Treatment-Resistant DepressionNCT01640080 · 2012-06-27
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.